PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 139 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,517,497 | +11.0% | 43,795 | -7.3% | 0.00% | 0.0% |
Q1 2024 | $1,366,624 | +18.3% | 47,239 | -6.3% | 0.00% | 0.0% |
Q4 2023 | $1,155,489 | +30.5% | 50,392 | -5.1% | 0.00% | +100.0% |
Q3 2023 | $885,374 | -44.4% | 53,080 | -7.9% | 0.00% | -50.0% |
Q2 2023 | $1,592,238 | +39.3% | 57,648 | +16.0% | 0.00% | 0.0% |
Q1 2023 | $1,143,422 | +106.7% | 49,714 | -1.9% | 0.00% | +100.0% |
Q4 2022 | $553,159 | +32.3% | 50,702 | +2.3% | 0.00% | 0.0% |
Q3 2022 | $418,000 | +5.8% | 49,567 | -0.7% | 0.00% | 0.0% |
Q2 2022 | $395,000 | -70.2% | 49,938 | -10.9% | 0.00% | -50.0% |
Q1 2022 | $1,327,000 | -35.8% | 56,052 | -7.3% | 0.00% | 0.0% |
Q4 2021 | $2,068,000 | +106.6% | 60,465 | +7.0% | 0.00% | +100.0% |
Q3 2021 | $1,001,000 | -60.9% | 56,508 | -0.9% | 0.00% | -66.7% |
Q2 2021 | $2,558,000 | +85.9% | 57,003 | +7.3% | 0.00% | +50.0% |
Q1 2021 | $1,376,000 | +43.3% | 53,123 | +11.5% | 0.00% | +100.0% |
Q4 2020 | $960,000 | +7.1% | 47,624 | +3.9% | 0.00% | 0.0% |
Q3 2020 | $896,000 | +49.1% | 45,846 | +34.7% | 0.00% | 0.0% |
Q2 2020 | $601,000 | +216.3% | 34,044 | +26.8% | 0.00% | – |
Q1 2020 | $190,000 | +1.6% | 26,856 | +1.2% | 0.00% | – |
Q4 2019 | $187,000 | -41.4% | 26,542 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $319,000 | +12.7% | 26,542 | +13.7% | 0.00% | 0.0% |
Q2 2019 | $283,000 | +87.4% | 23,347 | +32.6% | 0.00% | – |
Q1 2018 | $151,000 | -59.6% | 17,613 | -2.0% | 0.00% | -100.0% |
Q4 2017 | $374,000 | +37.5% | 17,965 | +16.7% | 0.00% | 0.0% |
Q3 2017 | $272,000 | +44.7% | 15,400 | -7.2% | 0.00% | – |
Q2 2017 | $188,000 | -4.1% | 16,600 | +8.5% | 0.00% | – |
Q1 2017 | $196,000 | -43.2% | 15,300 | -2.5% | 0.00% | -100.0% |
Q4 2016 | $345,000 | +1.5% | 15,700 | -2.5% | 0.00% | 0.0% |
Q3 2016 | $340,000 | – | 16,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $84,864,191 | 21.18% |
Cannon Global Investment Management, LLC | 69,900 | $2,422,035 | 11.28% |
ADAR1 Capital Management, LLC | 1,603,932 | $55,576,244 | 10.49% |
Checkpoint Capital L.P. | 355,000 | $12,300,750 | 7.42% |
Fairmount Funds Management LLC | 931,890 | $32,289,989 | 3.65% |
BVF INC/IL | 3,319,290 | $115,013,399 | 3.22% |
RTW INVESTMENTS, LP | 5,286,404 | $183,173,899 | 2.84% |
Kynam Capital Management, LP | 800,000 | $27,720,000 | 2.14% |
683 Capital Management, LLC | 604,449 | $20,944,158 | 1.58% |
Birchview Capital, LP | 48,000 | $1,663,200 | 1.54% |